期刊文献+

慢病毒介导的Aurora A沉默对耐阿霉素人膀胱癌细胞凋亡的影响及机制

Silencing of Aurora A induces apoptosis and enhances chemosensitivity of adriamycin-resistance in human bladder cancer cells through down-regulation of MRP-1 and Bcl-2
原文传递
导出
摘要 目的探讨Aurora A在人膀胱癌细胞耐阿霉素(ADM)形成机制中的作用及影响。方法采用ADM浓度梯度递增诱导法建立ADM人膀胱癌T24细胞株(T24/ADM),MTT法检测不同浓度ADM(1μg/mL和2μg/mL)对T24和T24/ADM细胞的毒性作用,分别构建转染Aurora A RNAi慢病毒和空载体的T24/ADM细胞(T24/ADM/KD和T24/ADM/NC),2μg/mL阿霉素分别处理T24/ADM、T24/ADM/NC和T24/ADM/KD细胞24 h,Annexin V-FITC/PI和Western blot分别检测各组细胞凋亡率和MRP-1、Bcl-2蛋白表达水平。结果随着ADM浓度增加(2μg/mL ADM处理),T24/ADM细胞耐ADM的细胞毒性作用(22.8±2.0%)较T24细胞(52.5±11.6%)更加明显(P=0.035)。2μg/mL ADM作用于T24/ADM、T24/ADM/NC和T24/ADM/KD细胞24 h后,Annexin V-PE检测各组细胞的凋亡率分别为(6.61±0.44)%、(6.76±0.39)%和(24.43±1.77)%,T24/ADM和T24/ADM/NC细胞间的凋亡率比较,差异无统计学意义(P=0.88);T24/ADM/KD细胞的凋亡率较T24/ADM和T24/ADM/NC细胞显著增加(P<0.01)。2μg/mL ADM作用于T24/ADM、T24/ADM/NC和T24/ADM/KD细胞24 h后,Western blot检测显示T24/ADM/KD细胞的MRP-1和Bcl-2蛋白表达水平均低于T24/ADM和T24/ADM/NC细胞(P<0.05);T24/ADM与T24/ADM/NC细胞的MRP-1(P=0.92)和Bcl-2(P=0.31)蛋白表达水平比较,差异无统计学意义(P=0.31)。结论Aurora A可能通过调控MRP-1和Bcl-2的表达,影响T24/ADM细胞的凋亡和对阿霉素的耐药性,其在膀胱癌多药耐药的形成中可能发挥着重要作用。 Objective This study was designed to explore the role of Aurora A in the molecular mechanisms of multidrug resistance(MDR)of human bladder cancer cells.Methods Adriamycin(ADM)-resistance T24 cells(T24/ADM)was generated from T24 cells cultured within gradual increasing concentration of ADM.MTT assays was underwent to detect cells viability of T24 and T24/ADM cells treated with 1μg/mL and 2μg/mL ADM for 24 hours.The apoptosis and protein expression of T24/ADM,T24/ADM/NC and T24/ADM/KD was evaluated respectively by Annexin V-FITC/PI assay and Western blot.Results With the increase of ADM concentration(2μg/mL ADM treatment),the ADM-resistant cytotoxicity of T24/ADM cells(22.8±2.0%)was more obvious than that of T24 cells(52.5±11.6%)(P=0.035).Annexin V-PE was treated with μg/mL ADM on T24/ADM,T24/ADM/NC and T24/ADM/KD cells for 24 h.There was no significant difference in the apoptosis rates between T24/ADM and T24/ADM/NC cells(P=0.88).The apoptosis rate of T24/ADM/KD cells was significantly higher than that of T24/ADM and T24/ADM/NC cells(P<0.01).The 2μg/mL ADM was applied to T24/ADM,T24/ADM/NC and T24/ADM/KD cells for 24 h.The protein expression levels of MRP-1 and Bcl-2 in T24/ADM/KD cells were lower than those in T24/ADM and T24/ADM/NC cells(P<0.05).There was no significant difference in MRP-1(P=0.92)and Bcl-2(P=0.31)protein expression levels between T24/ADM and T24/ADM/NC cells(P=0.31).Conclusions Aurora A may affect apoptosis and adriamycin resistance of 124/ADM cells by regulating MRP-1 and Bcl-2 expression,and may play an important role in the formation of multidrug resistance in bladder cancer.
作者 肖宁 林玮键 唐琦 唐蓉玉 朱胜 郭广荣 龙永福 Xiao Nin;Lin Weijian;Tang Qi;Tang Rongyu;Zhu Sheng;Guo Guangrong;Long Yongfu(Department of Urology,the Second Affiliated Hospital of Guilin Medical University,Guilin 541199,China;Continence Research Clinic,Shaoyang Hospital Affiliated to University of South China,Shaoyang 422000,China;Department of Urology,the Shaoyang Central Hospital,Shaoyang 422000,China)
出处 《国际泌尿系统杂志》 2021年第6期981-984,共4页 International Journal of Urology and Nephrology
基金 湖南省临床医疗技术创新引导项目(2017SK51401) 湖南省卫健委科研计划课题项目(B2016184) 邵阳市科技计划项目(2015HN02)。
关键词 膀胱肿瘤 细胞系 Aurora A 阿霉素 Urinary Bladder Neoplasms Cell Line Aurora A Doxorubicin
  • 相关文献

参考文献3

二级参考文献23

  • 1SJ Moghaddam,EN Haghighi,S Samiee,N Shahid,AR Keramati,S Dadgar,MR Zali.Immunohistochemical analysis of p53,cyclinD1,RB1,c-fos and N-ras gene expression in hepatocellular carcinoma in Iran[J].World Journal of Gastroenterology,2007,13(4):588-593. 被引量:73
  • 2Parkin M D, Bray F,Ferlay J, et al. Global Cancer Statis-tics, 2002[J]. CA Cancer J Clin, 2005,55(2):74-108.
  • 3Marumoto T, Zhang D, Saya H. Aurora A a guardian of poles[J]. Nat Rev Cancer, 2005,5(1):42-50.
  • 4Gizatullin F, Yao Y, Kung V,et al. The Aurora kinase in-hibitor VX-680 induces endoreduplication and apoptosis prefer-entially in cells with compromised p53-Dependent postmitoticcheckpoint function[J]. Cancer Res, 2006,66(15):7668-7677.
  • 5Parkin D M. The global burden of urinary bladder cancer[J].Scand J Urol Nephrol, 2008, Suppl(218): 12-20.
  • 6Kleshner N E, Herr H W, Stewart A K, et al. The nationalcancer data base report on bladder carcinoma[J]. Cancer,1996,78(7):1505-1513.
  • 7Stenzl A, Cowan NC, De Santis M, et al. EAU Guidelineson bladder cancer muscle-invasive and metastatic[J]. EurUrol, 2009,55(4):815-825.
  • 8Harrington E A, Bebbington D, Moore J,et al. VX-680, apotent and selective small molecfJiLe inhibitor of the Aurora ki-nases , suppresses tumor growth in vivo[J]. Nature Med,2004,10(3):262-267.
  • 9Arlot-Bonnemains Y, Baldini E, Martin B, et al. Effects ofthe Aurora kinase inhibitor VX-680 on anaplastic thyroid can-cer-derived cell lines[J]. Endocr Relat Cancer, 2008,15(2):559-568.
  • 10Kim J K, Jung K H, Noh J H, et al. Targeted disruption ofS100P suppresses tumor cell growth by down-reg[J].Lation of cy-clinD1 and CDK2 in human hepatocelllxLar carcinoma[J]. IntJ Oncol, 2009,35(6):1257-1264.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部